Skip to main content Accessibility help
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2013
  • Online publication date: December 2013

Chapter 14 - Central post-stroke pain

from Section 4 - The Specific Condition: Central Neuropathic Pain


This chapter focuses on the voltage-gated sodium (Nav) channel and voltage-gated calcium channel (VGCC), since they are essential to pain transmission. The most basic structural plan of a eukaryotic voltage-gated ion channel consists of four sub-units surrounding a central pore, through which ions pass. Sodium channel inactivation is modulated by many factors, including toxins, disease states, mutations, and therapeutic drugs. In neurons, activation of VGCC in response to depolarized membrane potential leads to calcium entry, mediating calcium-dependent enzyme activation, gene expression, or release of neurotransmitters. Two main classes of VGCC have been reported, the T-type or low voltage activated (LVA) and the high voltage activated (HVA) channels. To manage different etiologies of neuropathic pain, a variety of therapeutic targets must be available. Drugs directed at specific targets, such as those channels expressed in nociceptors, or upregulated after injury, may give the best pain management while minimizing undesirable side effects.


1. EdingerL. Giebt es central antstehender Schmerzen?Dtsch Z Nervenheilk 1891;1:262–82.
2. DjerineJ, RoussyG. Le syndrome thalamique. Rev Neurol (Paris) 1906;14:521–32.
3. HanssonP. Post-stroke pain case study: clinical characteristics, therapeutic options and long term followup. Eur J Neurol 2004;11 (S1):22–30.
4. AndersenG, VestergaardK, Ingeman-NielsenM, et al. Incidence of central post-stroke pain. Pain 1995;61:187–93.
5. WidarM, SamuelssonL, Karlsson TeveniousS, et al. Long term pain condition after stroke. J Rehab Med 2002;34:165–70.
6. KongKH, WoonVC, YangSY. Prevalence of chronic pain and its impact on health-related quality of life in stroke survivors. Arch Phys Med Rehabil 2004;85:35–40.
7. SackleyC, BrittleN, PatelS, et al. The prevalence of joint contractures, pressure sores, painful shoulders, other pain, falls and depression in the year after a severely disabling stroke. Stroke 2008;39:3329–34.
8. TreedeRD, JensenTS, CampbellJN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008;70:1630–5.
9. JohnsonAC, LindgrenI, HallstromB, et al. Prevalence and intensity of pain after stroke: a population-based study focusing on patients’ perspectives. J Neurol Neurosurg Psychiatry 2006;77:590–5.
10. AppelrosP. Prevalence and predictors of pain and fatigue after stroke: a population-based study. Int J Rehabil Res 2006;29:329–33.
11. BowsherD. Stroke and central post-stroke pain in an elderly population. J Pain 2001;2:258–61.
12. KlitH, FinnerupNB, AndersenG, et al. Central poststroke pain: a population-based study. Pain 2011;152:818–24.
13. CanaveroS, BonicalziV. Central pain of brain origin: epidemiology and clinical features. In Central Pain Syndrome: Pathophysiology, Diagnosis and Management. 1st edition. Cambridge: Cambridge University Press; 2007, pp. 9–99.
14. KlitH, FinnerupNB, JensenTS. Central post-stroke pain: clinical characteristics, pathophysiology and management. Lancet Neurol 2009;8:857–68.
15. KumarB, KalitaJ, KumarG, et al. Central poststroke pain: a review of pathophysiology and treatment. Pain Med 2009;108:1645–57.
16. LamplC, YazdiK, RoperC. Amitriptyline in the prophylaxis of central poststroke pain: preliminary results of 39 patients in a placebo-controlled, long term study. Stroke 2002;33:3030–2.
17. KimJS. Central post-stroke pain or paresthesia in lenticulocapsular hemorrhages. Neurology 2003;61:679–82.
18. MacGowanDJ, JamalMN, ClarkWC, et al. Central poststroke pain and Wallenberg’s lateral medullary infarction: frequency, character and determinants in 63 patients. Neurology 1997;49:120–55.
19. HeadH, HolmesG. Sensory disturbances from cerebral lesions. Brain 1911;34:102–254.
20. TaskerRR, de CarvalhoG, DostrovskyJO. The history of central pain syndrome with observations concerning pathophysiology and treatment. In CaseyKL, ed. Pain and Central Nervous System Disease: The Central Pain Syndromes. New York, NY: Raven Press; 1991, pp. 31–58.
21. TaskerRR. Identification of pain processing systems by electrical stimulation of the brain. Human Neurobiol 1982;1:261–72.
22. HongJH, ChoiBY, ChangCH, et al. The prevalence of central poststroke pain according to the integrity of the spino-thalamo-cortical pathway. Eur Neurol 2012;61:12–17.
23. KumarG, SoniCR. Central post-stroke pain: current evidence. J Neurol Sci 2009;284:10–17.
24. FinnerupNB, SindrupSH, JensenTS. The evidence for pharmacological treatment of neuropathic pain. Pain 2010;150:573–81.
25. LeijonG, BoivieJ. Central post-stroke pain – a controlled trial of amitriptyline and carbamazepine. Pain 1989;36:27–36.
26. VestergaardK, AndersenG, JensenTS. Treatment of central post-stroke pain with a selective serotonin reuptake inhibitor. Eur J Neurol 1996;3 (Suppl 5):169.
27. ShimodozonoM, KawahiraK, KamishitaT, et al. Reduction of central poststroke pain with the selective serotonin reuptake inhibitor fluvoxamine. Int J Neurosci 2002;112:1173–81.
28. VrankenJH, DijkgraafMG, KruisMR, et al. Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen. Pain 2008;136:150–7.
29. KimJS, BashfordG, MurphyTK, et al. Safety and efficacy of pregabalin in patients with central post-stroke pain. Pain 2011;152:1018–23.
30. SerpellMG. Neuropathic pain study group. Gabapentin in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial. Pain 2002;99:557–66.
31. JungehulsingGJ, IsraelH, SafarN, et al. Levetiracetam in patients with central neuropathic post-stroke pain – a randomized, double-blind, placebo-controlled trial. Eur J Neurol 2013;20:331–7
32. VestergaardK, AndersenG, GottrupH, et al. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology 2001;56:184–90.
33. RowbothamMC, TwillingL, DaviesPS, et al. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 2003;348:1223–32.
34. AttalN, GuirimandF, BrasseurL, et al. Effects of IV morphine in central pain: a randomized placebo-controlled study. Neurology 2002;58:554–63.
35. AttalN, GaudeV, BrasseurL, et al. Intravenous lidocaine in central pain: a double-blind, placebo-controlled, psychophysical study. Neurology 2000;54:564–74.
36. CanaveroS, BonicalziV. Intravenous subhypnotic propofol in central pain: a double-blind, placebo-controlled, crossover study. Clin Neuropharmacol 2004;27:182–6.
37. McQuayHJ, CarrollD, JadadAR, et al. Dextromethorphan for the treatment of neuropathic pain: a double-blind randomized controlled crossover trial with integral n-of-1 design. Pain 1994;59:127–33.
38. BaintonT, FoxM, BowsherD, et al. A double blind trial of naloxone in central post stroke pain. Pain 1992;48:159–62.
39. KhedrEM, KorbH, KamelNP, et al. Long-lasting antalgic effects of daily sessions of respective transcranial magnetic stimulation in central and peripheral neuropathic pain. J Neurol Neurosurg Psychiatry 2005;76:833–8.
40. LefaucheurJP, DrouotX, Menard-LefaucheurI, et al. Neurogenic pain relief by repetitive transcranial magnetic cortical stimulation depends on the origin and the site of pain. J Neurol Neurosurg Psychiatry 2004;75:612–16.
41. SaitohY, OsakiY, NishimuraH, et al. Increased regional cerebral blood flow in the contralateral thalamus after successful motor cortex stimulation in a patient with poststroke pain. J Neurosurg 2004;100:935–9.
42. KatayamaY, YamamotoT, KobayashiK, et al. Motor cortex stimulation for post-stroke pain: comparison of spinal cord and thalamic stimulation. Stereotac Funct Neurosurg 2001;77:183–6.
43. SaitohY, ShibataM, HiranoS, et al. Motor cortex stimulation for central and peripheral deafferentation pain: report of eight cases. J Neurosurg 2000;92:150–5.
44. CruccuG, AzizTZ, Garcia-LarreaL, et al. EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol 2007;14:952–70.
45. OwenSL, GreenAL, SteinJF, et al. Deep brain stimulation for the alleviation of post-stroke neuropathic pain. Pain 2006;120:202–6.
46. LeungA, DonohueM, XuR, et al. rTMS for suppressing neuropathic pain: a meta-analysis. J Pain 2009;10:1205–16.
47. LimaMC, FregniF. Motor cortex stimulation for chronic pain: systematic review and meta-analysis of the literature. Neurology 2008;70:2329–37.